Quick Answer
Medinotec Inc. reported Research And Development Expense of -$91.1 thousand for the year ending 2025.
- Medinotec Inc. showed a decrease of -307.7% in Research And Development Expense from 2024 to 2025.
- This data is from Medinotec Inc.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: -$12.6 thousand | Q2 2022: -$34.1 thousand | Q3 2022: $21.9 thousand | Q3 2022: -$6.4 thousand | Q4 2022: $6.4 thousand | Q2 2023: -$2.3 thousand | Q3 2023: $11.9 thousand | Q4 2023: $2.7 thousand | Q2 2024: -$15.0 thousand | Q3 2024: $1.9 thousand | Q4 2024: $69.3 thousand | Q2 2025: -$49.0 thousand | Q3 2025: $66.2 thousand | Q4 2025: $8.3 thousand.
- Over the full 3 years of available data (2023 to 2025), Medinotec Inc.'s Research And Development Expense has declined by 40.5%.
- Historical annual values: Fiscal year 2025: -$91.1 thousand | Fiscal year 2024: -$22.4 thousand | Fiscal year 2023: -$64.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: